Literature DB >> 11232189

Hepatocellular cancer. A century of progress.

M C Kew1.   

Abstract

Although gratifying progress has been made during the 20th century, much remains to be achieved. The principal objective must be prevention of HCC. Prevention of HBV-related tumors is already feasible, and prevention of HCV-related and aflatoxin-induced tumors should soon become possible. Not all HCCs are yet accounted for causatively, and the remaining risk factors need to be identified. Until primary prevention can be accomplished, attention must also be directed to obtaining a complete understanding of the pathogenesis of HCC so that strategies for secondary and tertiary prevention can be formulated and instituted. Finally, the search for effective anticancer treatment must continue.

Entities:  

Mesh:

Year:  2000        PMID: 11232189     DOI: 10.1016/s1089-3261(05)70107-0

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  8 in total

1.  The effect of co-administration of Lawsonia inermis extract and octreotide on experimental hepatocellular carcinoma.

Authors:  N M Abdel-Hamid; O M Mohafez; M H Nazmy; A Farhan; K Thabet
Journal:  Environ Health Prev Med       Date:  2015-03-01       Impact factor: 3.674

2.  Liver transplantation for hepatocellular carcinoma: the ochsner experience.

Authors:  George E Loss; Satheesh Nair; Jamie L Blazek; Gist H Farr; James D Eason
Journal:  Ochsner J       Date:  2002

Review 3.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

4.  Recent developments in the first detection of hepatocellular carcinoma.

Authors:  Joseph B Lopez
Journal:  Clin Biochem Rev       Date:  2005-08

Review 5.  Screening for hepatocellular carcinoma: why, when, how?

Authors:  Miguel R Arguedas
Journal:  Curr Gastroenterol Rep       Date:  2003-02

6.  Protrusion-localized STAT3 mRNA promotes metastasis of highly metastatic hepatocellular carcinoma cells in vitro.

Authors:  Yan-Hong Liu; Jia-Lu Jin; Yu-Zhe Wang; Ying Tan; Ying-Ying Zhou; Ting Peng; Feng Li; Wan-Dong Liang; Pascal Chartrand; Yu-Yang Jiang; Zhi-Fa Shen
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

7.  Malignant liver tumors in South African children: a national audit.

Authors:  S W Moore; A Davidson; G P Hadley; M Kruger; J Poole; D Stones; L Wainwright; G Wessels
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

8.  Hepatic somatostatin receptor 2 expression during premalignant stages of hepatocellular carcinoma.

Authors:  N M Abdel-Hamid; O M Mohafez; S Zakaria; K Thabet
Journal:  Tumour Biol       Date:  2013-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.